The global fertility services market size was valued at USD 48.15 billion in 2025 and is projected to grow from USD 51.36 billion in 2026 to USD 86.09 billion by 2034, registering a CAGR of 6.67% during the forecast period from 2026 to 2034. Europe dominated the fertility services market with a market share of 35.8% in 2025.
Fertility services include medical treatments and supportive care that help individuals and couples overcome infertility and improve their chances of having a child. These services include fertility testing, in vitro fertilization (IVF), artificial insemination, egg and sperm donation, and fertility preservation. Demand is growing due to rising infertility rates, delayed pregnancies, increasing awareness, and continuous advances in reproductive medicine.
Download a Free Sample To learn more about this report,
Increasing Adoption of Fertility Preservation Services
The fertility services market is expanding beyond infertility treatment toward fertility preservation, including oocyte and embryo cryopreservation. This shift is being supported by patients seeking to preserve reproductive options before medical treatment or because they anticipate age-related fertility decline. Fertility clinics are therefore broadening service portfolios to address reproductive planning at different stages of life.
In March 2025, updated clinical guidance formally recommended that fertility preservation be incorporated into survivorship care for people with cancer and recognized in-vitro maturation of oocytes as an emerging preservation option.
Growing Use of Assisted Reproductive Technology
Assisted reproductive technology is becoming an increasingly important component of fertility care as patients use IVF and related procedures to address infertility. Improvements in laboratory procedures, embryo management, and clinical monitoring are supporting wider utilization of these services. The increasing volume of ART procedures is also strengthening demand for specialized fertility clinics, reproductive laboratories, and associated services.
In December 2024, U.S. surveillance data reported 435,426 assisted reproductive technology cycles performed in 2022 across 457 reporting clinics.
High Global Prevalence of Infertility Supports Demand for Fertility Care
The large number of people experiencing infertility creates a substantial underlying need for diagnostic and treatment services. Infertility can result from male, female, or combined reproductive factors, requiring patients to seek evaluation and potentially multiple forms of medical intervention. As awareness and diagnosis improve, more individuals and couples are entering formal fertility-care pathways.
In November 2025, the World Health Organization estimated that approximately one in six people of reproductive age experience infertility during their lifetime.
High Out-of-Pocket Treatment Costs Limit Access to Fertility Services
Fertility treatment can require substantial expenditure because patients may need repeated diagnostic procedures, medication, laboratory services, and treatment cycles. Limited insurance coverage and high direct payments can discourage patients from initiating or continuing treatment, particularly in countries where fertility care is largely privately funded. Cost therefore remains a major barrier to broader market penetration.
In November 2025, the World Health Organization reported that infertility tests and treatments are largely financed out of pocket in many countries and that a single IVF round can cost more than the average annual household income in some settings.
Expansion of Fertility Services for Cancer Survivors Creates New Demand
Advances in cancer survival are creating a broader population that may require reproductive health support after treatment. Fertility preservation and post-treatment reproductive counseling can become integrated into cancer-care pathways, creating opportunities for fertility clinics to collaborate with oncology providers. This expands fertility services into survivorship care rather than limiting demand to patients initially seeking infertility treatment.
In March 2025, updated oncology guidance recommended that healthcare providers address fertility preservation not only at cancer diagnosis but also as part of survivorship care.
Variability in Fertility Treatment Outcomes Complicates Patient Decision-Making
Fertility treatment outcomes vary according to factors such as patient age, infertility diagnosis, previous pregnancy history, and treatment procedure. This variability makes it difficult for patients to predict individual outcomes and can require repeated treatment cycles before achieving a successful pregnancy. Fertility providers must therefore manage expectations while maintaining accurate treatment counseling and outcome reporting.
In February 2025, U.S. fertility-care guidance emphasized that assisted reproductive technology success rates differ according to patient characteristics and treatment type, and that national or clinic-level averages may not represent an individual patient's probability of success.
IVF with Intracytoplasmic Sperm Injection (IVF with ICSI) Segment Dominated the Market with 41.7% Share in 2025
The IVF with intracytoplasmic sperm injection (IVF with ICSI) segment dominated the global fertility services market with a 41.7% share in 2025. This procedure is widely used to treat male infertility and improve the chances of successful fertilization. Its high success rate and growing acceptance among couples facing fertility challenges continue to make it the most commonly performed fertility procedure.
The intrauterine insemination (IUI) and IVF without ICSI segments are also growing steadily. IUI remains a preferred option for couples with mild fertility issues because it is less invasive and more affordable, while conventional IVF continues to be widely used for various infertility conditions. Surrogacy is also gaining popularity as more people seek alternative family-building options due to medical or reproductive challenges.
The others segment continues to grow with the introduction of advanced reproductive techniques and personalized fertility treatments. Ongoing improvements in assisted reproductive technologies are expected to support growth across all fertility procedures.
Request Customizationto receive a tailored report.
Fresh Non-donors Segment Dominated the Market with 32.5% Share in 2025
The fresh non-donors segment dominated the global fertility services market with a 32.5% share in 2025. Many couples prefer using their own fresh eggs and sperm because it offers a natural treatment approach and has been widely adopted in fertility clinics. Growing awareness of assisted reproductive technologies continues to support demand for this service.
The frozen non-donors and egg & embryo banking segments are expanding steadily as more patients choose fertility preservation before medical treatments or delayed parenthood. Fresh donors and frozen donors are also seeing increased demand, providing additional treatment options for individuals and couples facing complex fertility challenges.
Advances in cryopreservation technology and improved embryo storage techniques are expected to increase the adoption of fertility preservation services across all treatment categories.
Fertility Clinics Segment Dominated the Market with 62.8% Share in 2025
The fertility clinics segment dominated the global fertility services market with a 62.8% share in 2025. Specialized fertility clinics offer advanced reproductive technologies, experienced specialists, and personalized treatment plans, making them the preferred choice for infertility treatment. The growing number of dedicated fertility centers continues to strengthen this segment.
The hospitals and surgical centers segments are also growing steadily as healthcare providers expand their reproductive medicine services. Hospitals continue to offer comprehensive fertility care, while surgical centers support procedures related to reproductive health with shorter recovery times and specialized facilities.
The clinical research institutes segment is also expanding as research into reproductive medicine, fertility preservation, and new treatment methods continues to grow. Increasing investment in fertility research is expected to support innovation across the market.
Female Fertility Services Segment Dominated the Market with 62.6% Share in 2025
The female fertility services segment dominated the global fertility services market with a 62.6% share in 2025. The high demand for ovulation treatments, IVF procedures, fertility preservation, and reproductive health services continues to drive this segment. Rising awareness of women's reproductive health and delayed pregnancies have further increased the need for specialized fertility care.
The male fertility services segment is also growing steadily as awareness of male infertility increases and more men seek diagnosis and treatment. Advances in sperm analysis, fertility testing, and assisted reproductive technologies are helping improve treatment outcomes for male infertility.
Growing awareness, better access to fertility treatments, and continuous improvements in reproductive technologies are expected to support long-term growth across both male and female fertility services.
Speak to an Analystto discuss market opportunities.
North America fertility services market accounted for 30.4% of the global market, reaching USD 14.64 billion in 2025, and is projected to grow at a CAGR of 8.25% during the forecast period. The market is growing as more people are choosing assisted reproductive technologies due to delayed pregnancies, infertility issues, and greater awareness of fertility treatments. Better healthcare infrastructure and continuous advancements in fertility procedures are also supporting market growth.
The U.S. market was valued at USD 12.44 billion in 2025, making it the largest contributor in North America. Rising demand for IVF treatments, increasing awareness of reproductive health, and the availability of advanced fertility clinics continue to drive market growth.
Canada's market reached USD 2.20 billion in 2025. Growing access to fertility treatments, supportive healthcare programs, and increasing awareness of reproductive health continue to support steady market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe fertility services market accounted for 35.8% of the global market, reaching USD 17.24 billion in 2025, and is expected to register a CAGR of 8.65% during the forecast period. The region continues to lead the market because of strong healthcare systems, increasing use of assisted reproductive technologies, and supportive government policies in several countries. Rising maternal age is also contributing to higher demand for fertility services.
Germany's market accounted for USD 5.00 billion in 2025. Growing demand for fertility treatments, advanced healthcare facilities, and increasing acceptance of assisted reproduction continue to support market growth.
The UK market was valued at USD 3.45 billion in 2025. Expanding fertility clinics, increasing awareness of reproductive health, and wider access to fertility treatments continue to contribute to market growth.
Asia Pacific fertility services market accounted for 22.6% of the global market, valued at USD 10.88 billion in 2025, and is projected to register a CAGR of 10.85% during the forecast period. Growing healthcare investments, increasing infertility rates, and rising awareness of assisted reproductive technologies are driving market growth across the region. Improving healthcare infrastructure and supportive government initiatives are also creating new opportunities.
Japan's market generated USD 1.96 billion in 2025. Rising maternal age, increasing use of IVF procedures, and supportive fertility policies continue to support market growth.
China's market accounted for USD 5.66 billion in 2025, representing the largest share within Asia Pacific. A large patient population, growing number of fertility clinics, and increasing healthcare spending continue to drive market growth.
Latin America fertility services market accounted for 6.1% of the global market, reaching USD 2.94 billion in 2025, and is projected to grow at a CAGR of 8.75% during the forecast period. Better access to fertility treatments, improving healthcare infrastructure, and rising awareness of reproductive health are supporting market growth across the region.
Brazil's market reached USD 1.50 billion in 2025. Growing demand for assisted reproductive treatments, expanding private fertility clinics, and increasing healthcare investments continue to create growth opportunities.
Middle East & Africa fertility services market accounted for 5.1% of the global market, totaling USD 2.46 billion in 2025, and is anticipated to grow at a CAGR of 7.95% during the forecast period. Increasing awareness of infertility treatment, improving healthcare facilities, and growing investment in reproductive healthcare are supporting market growth across the region.
The UAE market was valued at USD 0.89 billion in 2025. Rising demand for advanced fertility treatments, expanding fertility clinics, and government investment in healthcare services continue to support market growth.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
India Pharmaceutical Stability and Storage Services Market Size, Share & Trends | Industry Report, 2034
Healthcare Regulatory Affairs Outsourcing Market Size, Share, 2034
Facial Fat Transfer Market Size, Share, Growth, Analysis, 2034
Viral Vector Manufacturing Market Size, Share, Growth, Analysis, 2034
Medical Equipment Rental Market Size, Share, Growth, 2034
Pharmaceutical Stability and Storage Services Market Size, 2034
We are featured on:
sales@straitsresearch.com